Venkaiah Naidu, Muppavarapu Venkaiah Naidu, M Venkaiah Naidu, Vice President of India, BJP, Bharatiya Janata Party, Bharat Biotech, Hyderabad, World Health Organisation, WHO, Rotavac 5D
The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. For vaccines to result in actual vaccination of people, highly…
The Indian government on Saturday dismissed reports claiming that people who are fully vaccinated with Covaxin may not qualify for travelling abroad as several countries are yet to approve the vaccine.Union Information and Broadcasting…
After the alleged death of a volunteer enrolled in Bharat Biotech's Covaxin clinical trial in Bhopal, the Hyderabad-based company clarified on Saturday that the death was unrelated to the vaccine and the probable cause of death was cardio…
Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with…
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for…
Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on "how to vaccinate 1.3 billion (130 crore) people with two injectable doses.…
Leading pharmaceutical company Bharat Biotech will use Kansas-based ViroVax's adjuvant Alhydroxiquim-II to boost the immune response to its coronavirus vaccine Covaxin.Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2…